Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ankylosing spondylitis
Pharma
UCB collects 3 new FDA approvals for blockbuster hopeful Bimzelx
Along with psoriasis, the biologic is now approved to treat psoriatic arthritis, non-radiographic axial spondyloarthritis and ankylosing spondylitis.
Zoey Becker
Sep 23, 2024 12:12pm
Trial win sets up AbbVie's Rinvoq up for likely Crohn's approval
May 12, 2022 9:52am
AbbVie's red-hot Rinvoq picks up 4th FDA nod in 5 months
Apr 29, 2022 5:05pm
AbbVie says Rinvoq, Skyrizi combined will outperform Humira
Jan 11, 2022 6:15pm
AbbVie's Rinvoq hunts for ankylosing spondylitis nods in EU, US
Jan 10, 2022 9:50am
AbbVie's Rinvoq, Pfizer's Xeljanz nab JAK label expansions
Dec 15, 2021 10:58am
